✦ LIBER ✦

Atypical antipsychotics are no more effective or tolerable than conventional antipsychotic schizophrenia treatments

✍ Scribed by KAHN, R

Book ID: 123556974
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 369 KB
Volume: 5
Category: Article
ISSN: 1462-9410
DOI: 10.1016/S1462-9410(01)90422-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum lipid profiles and schizophrenia:

Serum lipid profiles and schizophrenia: Effects of conventional or atypical antipsychotic drugs in Taiwan

✍ Tiao-Lai Huang; Jung-Fu Chen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 86 KB

PMH22 CONVENTIONAL ANTIPSYCHOTICS CAN BE

PMH22 CONVENTIONAL ANTIPSYCHOTICS CAN BE COST EFFECTIVE FOR BROADLY DEFINED TREATMENT RESISTANT OR INTOLERANT SCHIZOPHRENIA

✍ L Davies; S Lewis; K Hay Hurst 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

Safety and tolerability of once monthly

Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole

✍ Potkin, Steven G.; Raoufinia, Arash; Mallikaarjun, Suresh; Bricmont, Patricia; P 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 534 KB

PW01-178 - Effectiveness, tolerability a

PW01-178 - Effectiveness, tolerability and compliance of schizophrenic patients under treatment with oral atypical antipsychotics or long-acting injectable risperidone in daily routine

✍ Schreiner, A.; Ibach, B.; Hargarter, L.; Diekamp, B. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 32 KB

The impact upon extra-pyramidal side eff

The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia

✍ C. W. Ritchie; E. Chiu; S. Harrigan; K. Hall; A. Hassett; S. Macfarlane; M. Mast 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Abstract ## Background Atypical antipsychotics are commonly used in the management of schizophrenia in late life with evidence suggesting they induce lower rates of motor disturbance, but have similar efficacy to conventional antipsychotics. Trials in the elderly have been either retrospective,